Search

Haleon PLC

Closed

Sector Healthcare

388.7 0.28

Overview

Share price change

24h

Current

Min

387.8

Max

389.7

Key metrics

By Trading Economics

Income

58M

423M

Sales

-144M

2.8B

P/E

Sector Avg

29.48

103.001

EPS

0.033

Dividend yield

1.275

Profit margin

14.491

EBITDA

-2M

687M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-3.4 downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.27%

7.76%

Next Dividend date

19 Sept 2024

Market Stats

By TradingEconomics

Market Cap

59M

35B

Previous open

388.42

Previous close

388.7

News Sentiment

By Acuity

50%

50%

42 / 365 Healthcare

Haleon PLC Chart

Related News

1 Aug 2024, 06:54 UTC

Earnings

Haleon Lifts Profit Guidance on Profit Rise

26 Jun 2024, 13:33 UTC

Acquisitions, Mergers, Takeovers

Haleon to Sell Nicotine-Quitting Aid Business for $634 Million -- Update

26 Jun 2024, 12:32 UTC

Acquisitions, Mergers, Takeovers

Haleon to Sell Nicotine-Quitting Aid Business for $634 Million

17 May 2024, 06:24 UTC

Acquisitions, Mergers, Takeovers

GSK Sells Last Haleon Shares for $1.58 Billion

16 May 2024, 16:46 UTC

Acquisitions, Mergers, Takeovers

GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update

16 May 2024, 16:28 UTC

Acquisitions, Mergers, Takeovers

GSK to Sell Stake in Haleon Valued at About $1.61 Billion

1 Aug 2024, 13:08 UTC

Market Talk
Earnings

Haleon 1H Results Are Positive -- Market Talk

1 Aug 2024, 07:08 UTC

Market Talk
Earnings

Haleon's 1H Results Don't Surprise -- Market Talk

1 Aug 2024, 06:09 UTC

Earnings

Haleon Launches BuyBack Program Up to GBP185M

1 Aug 2024, 06:05 UTC

Earnings

Haleon Now Expects 2024 Operating Profit Growth to Grow High-Single Digit

1 Aug 2024, 06:04 UTC

Earnings

Haleon Had Seen Organic Revenue Growth of 4% to 6%

1 Aug 2024, 06:04 UTC

Earnings

Haleon Backs 2024 Organic Revenue Growth View

1 Aug 2024, 06:03 UTC

Earnings

Haleon Declares Interim Dividend of 2.0p per share

1 Aug 2024, 06:02 UTC

Earnings

Haleon 1H Adj EBIT Consensus GBP1.275B

1 Aug 2024, 06:02 UTC

Earnings

Haleon 1H Adj Oper Pft GBP1.29B

1 Aug 2024, 06:01 UTC

Earnings

Haleon 1H Organic Rev Growth Consensus 3.5%

1 Aug 2024, 06:01 UTC

Earnings

Haleon 1H Organic Rev Growth 3.5%

1 Aug 2024, 06:01 UTC

Earnings

Haleon 1H Revenue Consensus GBP5.69B

1 Aug 2024, 06:01 UTC

Earnings

Haleon 1H Rev GBP5.69B

26 Jun 2024, 11:54 UTC

Acquisitions, Mergers, Takeovers

Haleon: All Other 2024 Guidance Unchanged

26 Jun 2024, 11:54 UTC

Acquisitions, Mergers, Takeovers

Haleon: Sale Will Dilute 2024 Rev by 0.5%, Adj Oper Pft by 1%

26 Jun 2024, 11:52 UTC

Acquisitions, Mergers, Takeovers

Haleon: Sale Allow For NRT Exit Outside US, Trims Business Complexity

26 Jun 2024, 11:51 UTC

Acquisitions, Mergers, Takeovers

Haleon: Deal Expected to Complete Early 4Q

26 Jun 2024, 11:50 UTC

Acquisitions, Mergers, Takeovers

Haleon: Use of Proceeds Will Be in Line With Capital Allocation Priorities

26 Jun 2024, 11:49 UTC

Acquisitions, Mergers, Takeovers

Haleon: Deal Structure Upfront Cash GBP458M, GBP42M Performance-Based Payable

26 Jun 2024, 11:48 UTC

Acquisitions, Mergers, Takeovers

Haleon: Portfolio Includes Nicotinell, Nicabate, Habitrol and Thrive Available in Gum, Lozenge

26 Jun 2024, 11:47 UTC

Acquisitions, Mergers, Takeovers

Haleon: Deal Worth GBP500M With Additional Proceeds From Inventory Transfer

26 Jun 2024, 11:46 UTC

Acquisitions, Mergers, Takeovers

Haleon to Sell Non-US Nicotine Replacement Therapy Business to Dr. Reddy's Laboratories

17 May 2024, 06:09 UTC

Acquisitions, Mergers, Takeovers

GSK Sells Last Haleon Shares for $1.58 Bln

16 May 2024, 15:46 UTC

Acquisitions, Mergers, Takeovers

GSK PLC: Shares Are Equivalent to Around 4.2% of Haleon's Share Capital

Haleon PLC Forecast

Price Target

By TipRanks

-3.4% downside

12 Months Forecast

Average 374.9 GBX  -3.4%

High 447 GBX

Low 300 GBX

Based on 10 Wall Street analysts offering 12 month price targets forHaleon PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

5

Buy

4

Hold

1

Sell

Sentiment

By Acuity

42 / 365 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Haleon PLC

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.